We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -0.26% | 233.80 | 233.80 | 234.20 | 234.80 | 233.60 | 234.20 | 41,968 | 08:22:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 2.14B | 130.3M | 0.0636 | 36.73 | 4.8B |
Date | Subject | Author | Discuss |
---|---|---|---|
03/7/2019 12:47 | 300k buy Seems to be gathering momentum,finish over 150p would be significant | susiebe | |
03/7/2019 09:18 | Resistance is futile - Although it's hard to crack. Next 2/3 trading days, will IMO offer longer term risk / reward. It has to break out above 150p. | stoneme | |
01/7/2019 07:09 | Breakout starting | ny boy | |
28/6/2019 15:27 | That dip and recovery at 3.30 shows exactly where this is heading | susiebe | |
28/6/2019 11:18 | Yes looking primed!Lovely looking chart too | susiebe | |
28/6/2019 10:32 | Once we get thru 147/148p resistance, clear to go to 190p, the next resistance target. | ny boy | |
28/6/2019 08:10 | Surprised not many in this obvious takeover target! | ny boy | |
27/6/2019 13:49 | Aye I am staying patient, just like with (SIA) that is going well too. | ny boy | |
27/6/2019 10:36 | Another high volume daySurely only a matter of time before these break out... | susiebe | |
21/6/2019 07:48 | Agree, the recent price action make me think this could do well! When it breaks 150 I suspect it will attract more interest! | uhound | |
20/6/2019 10:37 | All good here, stay patient for a bid/bids, about to breakout of long term resistance first. Staying patient with STX as we await FDA game changing decision 27 July | ny boy | |
20/6/2019 07:10 | Another high volume day imoRead up and bought a few yesterday,good chance of recovery | susiebe | |
19/6/2019 11:49 | Surprised many on advfn haven’t twigged on this yet, certainly plenty of buying going on Waiting for the breakout | ny boy | |
18/6/2019 10:35 | Watch for a breakout on high volume. (FUL) being bought too | ny boy | |
18/6/2019 09:00 | Bidder circling, is what I hear, I have sorted to accumulate before the crowds arrive. | ny boy | |
29/5/2019 14:41 | On my watchlist, massive volume yesterday. | johnv | |
19/5/2019 13:02 | Turnaround plan, fantastic new CEO, potential Swedish bidders, way oversold and massive potential. So yes, a lot of hope. I give them a year and expect at least 50% return | jans3 | |
09/5/2019 13:21 | is there any hope for this company to turn around or is it too far gone? | smcni1968 | |
03/5/2019 13:20 | Ah, trading update | jans3 | |
03/5/2019 13:18 | Anyone know what is happening today? | jans3 | |
03/4/2019 13:55 | you can bet they have some Management Consultancy firm in there now shaking the whole thing up. Amazing to think that after float it just steadily went up to £3.20 or so. decent recovery stock this though imho.... | nickthe saint | |
02/4/2019 13:24 | and Peel Hunt reiterates its BUY recommendation and 230p target price | robow | |
02/4/2019 07:39 | from Citywire 26 Mar 19 AJ Bell: Convatec in need of a shake-up A management shake-up at medical equipment maker Convatec (CTEC) could be the start of a new way of thinking that could benefit investors, says AJ Bell. Convatec has poached Genus’ boss Karim Bitar to be its new chief executive to lead its turnaround effort just as the former is also losing its chairman and deputy chairman. ‘Convatec desperately needs a new lease of life as it has been a serial disappointment for most of its time as a listed business,’ said analyst Russ Mould. Last month, the group announced plans to invest $150 million over three years and Mould said ‘the scale of such investment was significantly greater than expected, despite having scope to deliver $120 million in annual savings by 2023, as well as improvements in revenue growth and profit margins’. | robow | |
29/3/2019 11:16 | This looks like a decent recovery stock. CEO buying some stock the other day and rumours of a potential bid. when are the next set of numbers out though? Probably not for a while.... | nickthe saint |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions